These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10331830)

  • 1. Patterns of prescribing ACE inhibitors after myocardial infarction.
    Luzier AB; Navsarikar A; Wilson MF; Ashai K; Forrest A
    Pharmacotherapy; 1999 May; 19(5):655-60. PubMed ID: 10331830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2.
    Barron HV; Michaels AD; Maynard C; Every NR
    J Am Coll Cardiol; 1998 Aug; 32(2):360-7. PubMed ID: 9708461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of appropriate use of angiotensin-converting enzyme inhibitors after acute myocardial infarction in persons > or = 65 years of age.
    Krumholz HM; Vaccarino V; Ellerbeck EF; Kiefe C; Hennen J; Kresowik TF; Gold JA; Jencks SF; Radford MJ
    Am J Cardiol; 1997 Mar; 79(5):581-6. PubMed ID: 9068512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early use of ACE inhibitors in the treatment of acute myocardial infarction in the United States: experience from the National Registry of Myocardial Infarction 2. National Registry of Myocardial Infarction 2 participants.
    Michaels AD; Maynard C; Every NR; Barron HV
    Am J Cardiol; 1999 Nov; 84(10):1176-81. PubMed ID: 10569326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are we inhibited? Renal insufficiency should not preclude the use of ACE inhibitors for patients with myocardial infarction and depressed left ventricular function.
    Frances CD; Noguchi H; Massie BM; Browner WS; McClellan M
    Arch Intern Med; 2000 Sep; 160(17):2645-50. PubMed ID: 10999979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure.
    Chin MH; Friedmann PD; Cassel CK; Lang RM
    J Gen Intern Med; 1997 Sep; 12(9):523-30. PubMed ID: 9294785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The problem of underdosing of angiotensin-converting enzyme inhibitors is markedly overrated: results from a study of patients discharged from hospital after an acute myocardial infarction.
    Kvan E; Reikvam A;
    Eur J Clin Pharmacol; 2004 May; 60(3):205-10. PubMed ID: 15034703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarction.
    Kizer JR; Cannon CP; McCabe CH; Mueller HS; Schweiger MJ; Davis VG; Perritt R; Antman EM
    Am Heart J; 1999 Jan; 137(1):79-92. PubMed ID: 9878939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibitors post-myocardial infarction.
    Young JB
    Cardiol Clin; 1995 Aug; 13(3):379-90. PubMed ID: 7585774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of angiotensin converting-enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction.
    Shlipak MG; Browner WS; Noguchi H; Massie B; Frances CD; McClellan M
    Am J Med; 2001 Apr; 110(6):425-33. PubMed ID: 11331052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: a multilevel study.
    Kasje WN; Denig P; Stewart RE; de Graeff PA; Haaijer-Ruskamp FM
    Eur J Clin Pharmacol; 2005 Apr; 61(2):145-51. PubMed ID: 15761751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals.
    Philbin EF; Andreaou C; Rocco TA; Lynch LJ; Baker SL
    Am J Cardiol; 1996 Apr; 77(10):832-8. PubMed ID: 8623735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of angiotensin-converting enzyme inhibitors in patients with acute myocardial infarction in community hospitals. Michigan State University Inter-Institutional Collaborative Heart (MICH) Study Group.
    Dwamena FC; El-Tamimi H; Watson RE; Kroll J; Stein AD; McLane A; Holmes-Rovner M; McIntosh B; Kupersmith J
    Clin Cardiol; 2000 May; 23(5):341-6. PubMed ID: 10803442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiologic and clinical effects of angiotensin-converting enzyme inhibitors in patients with prior myocardial infarction, nonsustained ventricular tachycardia, and depressed left ventricular function. MUSTT Investigators. Multicenter UnSustained Tachycardia Trial.
    Singh SN; Karasik P; Hafley GE; Pieper KS; Lee KL; Wyse DG; Buxton AE;
    Am J Cardiol; 2001 Mar; 87(6):716-20. PubMed ID: 11249889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of physician use of angiotensin converting enzyme inhibitors in the inpatient treatment of congestive heart failure.
    Ghali JK; Giles T; Gonzales M; Horswell R; Kumar S; Lejuene A; Livaudais GF; Sarkar IC
    J La State Med Soc; 1997 Dec; 149(12):474-84. PubMed ID: 9425858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002.
    Gislason GH; Abildstrom SZ; Rasmussen JN; Rasmussen S; Buch P; Gustafsson I; Friberg J; Gadsbøll N; Køber L; Stender S; Madsen M; Torp-Pedersen C
    Scand Cardiovasc J; 2005 Apr; 39(1-2):42-9. PubMed ID: 16097413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction: a class effect?
    Pilote L; Abrahamowicz M; Rodrigues E; Eisenberg MJ; Rahme E
    Ann Intern Med; 2004 Jul; 141(2):102-12. PubMed ID: 15262665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different angiotensin-converting enzyme inhibitors have similar clinical efficacy after myocardial infarction.
    Hansen ML; Gislason GH; Køber L; Schramm TK; Folke F; Buch P; Abildstrom SZ; Madsen M; Rasmussen S; Torp-Pedersen C
    Br J Clin Pharmacol; 2008 Feb; 65(2):217-23. PubMed ID: 17711535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.